Log In
Print this Print this

Acyline (MER 104)

  Manage Alerts
Collapse Summary General Information
Company Merrion Pharmaceuticals plc
DescriptionGonadotropin-releasing hormone (GnRH) antagonist
Molecular Target GnRH/LHRH receptor
Mechanism of ActionGnRH/LHRH receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today